Invesco
ROIV icon

Invesco’s Roivant Sciences ROIV Stock Holding History

Invesco’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267M Buy
7,531,192
+1,092,047
+17% +$32.3M 0.02% 627
2026
Q1 		$178M Buy
6,439,145
+4,157,658
+182% +$107M 0.02% 705
2025
Q4 		$49.5M Buy
2,281,487
+512,129
+29% +$10.1M ﹤0.01% 1091
2025
Q3 		$26.8M Buy
1,769,358
+85,259
+5% +$1.06M ﹤0.01% 1324
2025
Q2 		$19M Sell
1,684,099
-8,196,427
-83% -$88.8M ﹤0.01% 1462
2025
Q1 		$99.7M Buy
9,880,526
+365,468
+4% +$3.95M 0.02% 802
2024
Q4 		$113M Buy
9,515,058
+3,159,603
+50% +$37.4M 0.02% 780
2024
Q3 		$73.3M Buy
6,355,455
+447,390
+8% +$5.09M 0.01% 893
2024
Q2 		$62.4M Buy
5,908,065
+5,404,496
+1,073% +$59.2M 0.01% 924
2024
Q1 		$5.31M Sell
503,569
-424,479
-46% -$4.58M ﹤0.01% 2195
2023
Q4 		$10.4M Sell
928,048
-451,937
-33% -$4.4M ﹤0.01% 1790
2023
Q3 		$16.1M Buy
1,379,985
+47,547
+4% +$538K ﹤0.01% 1456
2023
Q2 		$13.4M Buy
1,332,438
+594,416
+81% +$5.32M ﹤0.01% 1596
2023
Q1 		$5.45M Buy
738,022
+237,234
+47% +$1.95M ﹤0.01% 2178
2022
Q4 		$4M Buy
500,788
+485,917
+3,268% +$2.7M ﹤0.01% 2358
2022
Q3 		$48K Sell
14,871
-318
-2% -$1.23K ﹤0.01% 3920
2022
Q2 		$62K Buy
+15,189
New +$60.3K ﹤0.01% 3949

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Invesco's ROIV Position: Q2 2026 in Review

Invesco increased its Roivant Sciences (ROIV) stake by 17% in Q2 2026, buying an estimated $32.3M and bringing the position to 7,531,192 shares worth $267M. The position accounts for 0.02% of the portfolio, ranked #627.

Invesco first reported a position in ROIV in Q2 2022 and has held it in 17 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Invesco held 7,531,192 shares of Roivant Sciences worth $267M as of Q2 2026.
  • Invesco bought 1,092,047 Roivant Sciences shares in Q2 2026, an estimated $32.3M.
  • Roivant Sciences made up 0.02% of Invesco's portfolio in Q2 2026, its #627 holding.
  • Invesco first reported a position in Roivant Sciences in Q2 2022 and has held it in 17 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.